Table 1.
Factors | Open | Robotic | p value | |
---|---|---|---|---|
Age, years | N | 643 | 331 | <0.001 |
Mean (SD) | 61.49 (7.07) | 59.71 (7.03) | ||
First elevated PSA | N | 432 | 195 | <0.001 |
Mean (SD) | 7.58 (5.22) | 5.89 (3.28) | ||
BMI | N | 597 | 299 | <0.001 |
Mean (SD) | 28.6 (4.0) | 27.3 (3.6) | ||
Non response rate | 7.2% | 9.7% | ||
CCS* | 0 | 512 (80) | 289 (87) | 0.004 |
≥1 | 131 (20) | 42 (13) | ||
Biopsy Gleason score N (%)** | Low/intermediate risk: Gleason 4, 5, 6, or 7 | 532 (88) | 310 (99) | <0.001 |
High risk: Gleason 8, 9, 10 | 76 (12) | 4 (1) | ||
Ethnicity*** | Caucasian: n(%) | 228 (75) | 98 (63) | 0.008 |
Non-Caucasian: n(%) | 75 (25) | 58 (37) | ||
PORPUS-P score | N | 437 | 210 | 0.024 |
Mean (sd) | 82.59 (11.10) | 84.73(11.26) | ||
Nerve-sparing status | None: n (%) | 155 (25) | 19 (7) | <0.001 |
Unilateral: n (%) | 146 (23) | 45 (15) | ||
Bilateral: n (%) | 326 (52) | 224 (78) |
Data are shown only for statistically significantly different characteristics. PORPUS-P: Patient-Oriented Prostate Utility Scale-Psychometric; PSA: prostate-specific antigen; CCS: Charlson comorbidity score; SD: standard deviation; RARP: robot-assisted radical prostatectomy; ORP: open radical prostatectomy.
All Charlson comorbidities are not captured in the PCDB. The following are captured: myocardial infarction, congestive heart failure, peripheral vascular disease, liver disease, diabetes mellitus, leukemia, lymphoma, AIDS, cerebrovascular Disease, dementia, pulmonary disease, rheumatologic disease, and peptic ulcer.
Missing biopsy Gleason scores: n = 35 ORP, n = 17 RARP.
Missing ethnicity: n = 340 ORP, n = 175 RARP.